Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 08:24 am Purchase | 2026-06-30 | 13G | TYRA BIOSCIENCES INC TYRA | Farallon Capital Management, L.L.C. | 6,000 0.000% | 6,000 (New Position) | Filing History |
| 2026-08-14 08:23 am Purchase | 2026-06-30 | 13G | TANGO THERAPEUTICS INC TNGX | Farallon Capital Management, L.L.C. | 16,270,187 9.800% | 16,270,187 (New Position) | Filing History |
| 2026-08-14 08:23 am Purchase | 2026-06-30 | 13G | SAVARA INC SVRA | Farallon Capital Management, L.L.C. | 15,000,000 6.800% | 3,224,368 (+27.38%) | Filing History |
| 2026-08-14 08:22 am Purchase | 2026-06-30 | 13G | INFLARX N V COM IFRX | Farallon Capital Management, L.L.C. | 3,325,000 2.300% | 3,325,000 (New Position) | Filing History |
| 2026-08-14 08:21 am Purchase | 2026-08-14 | 13D | EXELIXIS INC EXEL | Farallon Capital Management, L.L.C. | 13,989,010 5.600% | 13,989,010 (New Position) | Filing History |
| 2026-08-14 08:19 am Purchase | 2026-06-30 | 13G | ENANTA PHARMACEUTICALS INC ENTA | Farallon Capital Management, L.L.C. | 2,418,202 8.300% | 844,373 (+53.65%) | Filing History |
| 2026-08-13 5:20 pm Purchase | 2026-06-30 | 13G | REVOLUTION MEDICINES INC RVMD | Farallon Capital Management, L.L.C. | 13,564,149 6.400% | 13,564,149 (New Position) | Filing History |
| 2026-08-13 5:18 pm Purchase | 2026-06-30 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Farallon Capital Management, L.L.C. | 6,433,119 9.990% | 3,015,985 (+88.26%) | Filing History |
| 2026-08-13 5:17 pm Purchase | 2026-06-30 | 13G | MINERVA NEUROSCIENCES INC NERV | Farallon Capital Management, L.L.C. | 4,730,000 9.700% | 4,730,000 (New Position) | Filing History |
| 2026-08-13 5:16 pm Purchase | 2026-06-30 | 13G | PERSPECTIVE THERAPEUTICS, INC. CATX | Farallon Capital Management, L.L.C. | 5,583,479 8.600% | 5,583,479 (New Position) | Filing History |
| 2026-08-13 5:14 pm Purchase | 2026-06-30 | 13G | GRAIL INC GRAL | Farallon Capital Management, L.L.C. | 4,161,584 9.600% | 4,161,584 (New Position) | Filing History |
| 2026-08-13 5:13 pm Purchase | 2026-06-30 | 13G | BEAM THERAPEUTICS INC BEAM | Farallon Capital Management, L.L.C. | 10,282,210 9.990% | 10,282,210 (New Position) | Filing History |
| 2026-08-13 5:12 pm Purchase | 2026-06-30 | 13G | BETA BIONICS INC BBNX | Farallon Capital Management, L.L.C. | 595,000 1.300% | 595,000 (New Position) | Filing History |
| 2026-08-04 08:32 am Purchase | 2026-06-30 | 13G | LIQUIDIA CORPORATION COM LQDA | Farallon Capital Management, L.L.C. | 8,365,038 9.400% | 8,365,038 (New Position) | Filing History |
| 2026-08-04 08:29 am Purchase | 2026-06-30 | 13G | ASSEMBLY BIOSCIENCES INC N ASMB | Farallon Capital Management, L.L.C. | 1,604,590 8.100% | 1,604,590 (New Position) | Filing History |
| 2026-08-03 08:31 am Purchase | 2026-06-30 | 13G | BRIDGEBIO PHARMA INC BBIO | Farallon Capital Management, L.L.C. | 10,743,063 5.500% | 10,743,063 (New Position) | Filing History |
| 2026-08-03 08:30 am Purchase | 2026-06-30 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Farallon Capital Management, L.L.C. | 5,917,400 9.900% | 5,917,400 (New Position) | Filing History |
| 2026-08-03 08:29 am Purchase | 2026-06-30 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Farallon Capital Management, L.L.C. | 8,989,098 8.500% | 8,989,098 (New Position) | Filing History |
| 2026-06-26 08:58 am Sale | 2026-06-24 | 13D | CENTESSA PHARMACEUTICALS PLC S CNTA | Farallon Capital Management, L.L.C. | 0 0.000% | -9,370,093 (Position Closed) | Filing History |
| 2026-06-24 6:32 pm Purchase | 2026-06-16 | 13D | CENTESSA PHARMACEUTICALS PLC S CNTA | Farallon Capital Management, L.L.C. | 9,370,093 6.100% | 9,370,093 (New Position) | Filing History |